Latest news
A Blood Test Can See Risk. Policy Cannot Yet Hold It.
A JAMA study shows that plasma p-tau217 helps predict Alzheimer’s progression in cognitively unimpaired older adults. The science is moving fast. The ethics and policy are not.
WHO’s New AMR Plan Makes Stewardship and Access a Single Test
Physical activity continues to strengthen its case as a cross-disease prevention strategy
Can cortisol become the next target in type 2 diabetes?
The Air We Breathe May Be Shaping the Future Burden of Blindness
Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks
An ADC Steps Into the First-Line Gap in Triple-Negative Breast Cancer
Alpha Radioligand Therapy Moves Prostate Cancer Into a New Infrastructure Test
AI Pathology Starts Moving Toward Treatment Selection
Hepatitis B Functional Cure Moves Closer, But Access Still Starts With Diagnosis
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.